METHYL (E)-3-(1,3-BENZODIOXOL-5-YL)-2-PROPENOATE, 95.0%, 100mg

Infinity corrected plan phase S40x/0.65 objective. Working distance 0.36 mm

ROTI®Histofix, 500 ml, plastic

(S)-3-Pyrrolidinol>97.0%(GC)(T)25g

2-(Aminomethyl)-4-nitrophenol hydrochloride, 98%, 250mg

(3-Bromo-4-fluorophenyl)acetic acid methyl ester, 97.0%, 250mg

Tert-butyl 2-amino-2-cyclopropylacetate, 95%, 10g

Acetic acid, 2-cyano-, 2,2,2-trifluoroethyl ester, 95%, 250mg

4-Ethynylbiphenyl, 98.0%, 100g

4-Nitrocinnamic Acid>99.0%(T)10g

Methyl thieno[3,2-c]pyridine-6-carboxylate, 98%, 250mg

p-Toluenesulfinic acid, 90.0%, 25g

2-((Furan-2-ylmethyl)sulfinyl)acetic acid, 95%, 250mg